A dynamically interacting flexible loop assists oligomerisation of the Caenorhabditis elegans centriolar protein SAS-6.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
05 03 2019
Historique:
received: 04 10 2018
accepted: 11 02 2019
entrez: 7 3 2019
pubmed: 7 3 2019
medline: 22 9 2020
Statut: epublish

Résumé

Centrioles are conserved organelles fundamental for the organisation of microtubules in animal cells. Oligomerisation of the spindle assembly abnormal protein 6 (SAS-6) is an essential step in the centriole assembly process and may act as trigger for the formation of these organelles. SAS-6 oligomerisation is driven by two independent interfaces, comprising an extended coiled coil and a dimeric N-terminal globular domain. However, how SAS-6 oligomerisation is controlled remains unclear. Here, we show that in the Caenorhabditis elegans SAS-6, a segment of the N-terminal globular domain, unresolved in crystallographic structures, comprises a flexible loop that assists SAS-6 oligomerisation. Atomistic molecular dynamics simulations and nuclear magnetic resonance experiments suggest that transient interactions of this loop across the N-terminal dimerisation interface stabilise the SAS-6 oligomer. We discuss the possibilities presented by such flexible SAS-6 segments for the control of centriole formation.

Identifiants

pubmed: 30837637
doi: 10.1038/s41598-019-40294-2
pii: 10.1038/s41598-019-40294-2
pmc: PMC6401066
doi:

Substances chimiques

Caenorhabditis elegans Proteins 0
Cell Cycle Proteins 0
Recombinant Proteins 0
SAS-6 protein, C elegans 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3526

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N009274/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 094872/Z/10/Z
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/J008265/1
Pays : United Kingdom

Références

Cell. 2011 Feb 4;144(3):364-75
pubmed: 21277013
J Cell Biol. 2011 Jul 25;194(2):165-75
pubmed: 21788366
Mol Biol Cell. 2018 Mar 15;29(6):722-735
pubmed: 29367435
J Biomol NMR. 1995 Nov;6(3):277-93
pubmed: 8520220
Nat Commun. 2017 Mar 23;8:14813
pubmed: 28332496
Proc Natl Acad Sci U S A. 2013 Jul 9;110(28):11373-8
pubmed: 23798409
J Biol Chem. 2014 Jul 25;289(30):20727-39
pubmed: 24920673
Elife. 2017 Jan 16;6:
pubmed: 28092264
Expert Opin Ther Targets. 2015 Jul;19(7):957-72
pubmed: 25787715
Elife. 2015 May 23;4:e07236
pubmed: 26002084
J Eukaryot Microbiol. 2012 Sep;59(5):429-93
pubmed: 23020233
J Biol Chem. 2012 Mar 2;287(10):7182-9
pubmed: 22249178
J Mol Biol. 2018 Aug 3;430(16):2278-2287
pubmed: 29477337
Science. 2012 Aug 3;337(6094):553
pubmed: 22798403
Worm. 2013 Jul 1;2(3):e25214
pubmed: 24778935
J Cell Sci. 2010 May 1;123(Pt 9):1407-13
pubmed: 20388734
J Magn Reson. 2011 Dec;213(2):357-63
pubmed: 22152355
Nat Protoc. 2015 Jun;10(6):845-58
pubmed: 25950237
Dev Cell. 2011 Apr 19;20(4):563-71
pubmed: 21497766
J Mol Graph. 1996 Feb;14(1):33-8, 27-8
pubmed: 8744570
Sci Rep. 2016 Jun 08;6:27075
pubmed: 27272020
Nat Rev Cancer. 2015 Nov;15(11):639-52
pubmed: 26493645
Trends Genet. 2009 Nov;25(11):501-10
pubmed: 19850369
Biochemistry. 1992 Feb 18;31(6):1647-51
pubmed: 1737021
Nat Cell Biol. 2016 Apr;18(4):393-403
pubmed: 26999736
Nat Commun. 2014 Oct 24;5:5267
pubmed: 25342035
Dev Cell. 2013 May 13;25(3):284-98
pubmed: 23673331
Cell Microbiol. 2015 Feb;17(2):191-206
pubmed: 25154861
Dev Cell. 2011 Apr 19;20(4):550-62
pubmed: 21497765
Curr Biol. 2010 Sep 28;20(18):R816-25
pubmed: 20869612
J Cell Biol. 2014 Mar 3;204(5):697-712
pubmed: 24590172
Trends Genet. 2011 Aug;27(8):307-15
pubmed: 21680046
Structure. 2008 Jun;16(6):944-53
pubmed: 18547526
FEBS Lett. 2015 Sep 14;589(19 Pt A):2433-40
pubmed: 26073260
Curr Opin Cell Biol. 2009 Feb;21(1):14-9
pubmed: 19196504
Elife. 2015 May 29;4:e07410
pubmed: 26023830
Front Mol Biosci. 2018 Apr 30;5:39
pubmed: 29761107
Curr Top Dev Biol. 2008;85:1-22
pubmed: 19147000
Nat Cell Biol. 2005 Feb;7(2):115-25
pubmed: 15665853
Elife. 2014 Jan 01;3:e01812
pubmed: 24596152
Curr Biol. 2007 Dec 18;17(24):2169-74
pubmed: 18082404
Curr Biol. 2014 Nov 3;24(21):2526-32
pubmed: 25264260
Nat Rev Mol Cell Biol. 2015 Oct;16(10):611-24
pubmed: 26373263
Curr Opin Cell Biol. 2014 Feb;26:96-106
pubmed: 24529251
Dev Cell. 2009 Dec;17(6):900-7
pubmed: 20059959
Philos Trans R Soc Lond B Biol Sci. 2014 Sep 5;369(1650):
pubmed: 25047622
Science. 2011 Mar 4;331(6021):1196-9
pubmed: 21273447
Nat Rev Mol Cell Biol. 2012 Jun 13;13(7):425-35
pubmed: 22691849
Biochemistry. 1989 Nov 14;28(23):8972-9
pubmed: 2690953
Science. 2012 Jan 27;335(6067):422-6
pubmed: 22282802
Mol Biol Evol. 2008 Apr;25(4):778-86
pubmed: 18234705
EMBO J. 2012 Nov 14;31(22):4334-47
pubmed: 23064147
Sci Rep. 2016 Apr 14;6:24296
pubmed: 27075531
J Biomol NMR. 1994 Mar;4(2):171-80
pubmed: 8019132
Philos Trans R Soc Lond B Biol Sci. 2014 Sep 5;369(1650):
pubmed: 25047614
J Cell Biol. 2015 Jun 22;209(6):863-78
pubmed: 26101219
Open Biol. 2017 Dec;7(12):
pubmed: 29263250
Proteins. 2010 Jun;78(8):1950-8
pubmed: 20408171
Dev Cell. 2011 Apr 19;20(4):416-7
pubmed: 21497755

Auteurs

Julia M C Busch (JMC)

University of Oxford, Department of Biochemistry, Oxford, OX1 3QU, United Kingdom.

Michèle C Erat (MC)

University of Oxford, Department of Biochemistry, Oxford, OX1 3QU, United Kingdom.
University of Warwick, Mathematical Institute, Coventry, CV4 7AL, United Kingdom.

Iris D Blank (ID)

University of Oxford, Department of Biochemistry, Oxford, OX1 3QU, United Kingdom.

Maria Musgaard (M)

University of Oxford, Department of Biochemistry, Oxford, OX1 3QU, United Kingdom.
University of Ottawa, Department of Chemistry and Biomolecular Sciences, Ottawa, ON, K1N 6N5, Canada.

Philip C Biggin (PC)

University of Oxford, Department of Biochemistry, Oxford, OX1 3QU, United Kingdom.

Ioannis Vakonakis (I)

University of Oxford, Department of Biochemistry, Oxford, OX1 3QU, United Kingdom. ioannis.vakonakis@bioch.ox.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH